Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of aluminum on alkaline ribonuclease (
RNase
) and RNase inhibitor, purified from bovine brain, was investigated. Incubation of alkaline
RNase
with aluminum interrupted binding of RNase inhibitor to alkaline
RNase
. A stoichiometry of 1:1 for the binding of aluminum to brain alkaline
RNase
was estimated, whereas no aluminum was found to be bound to the RNase inhibitor. Aluminum-bound alkaline
RNase
, however, retained a full alkaline
RNase
activity. None of the enzyme-bound aluminum was dissociated by dialysis against 50 mM Hepes, pH 7.0, at 4 degrees C for 24 h.
Citrate
, EDTA, NaF and apotransferrin protected the alkaline
RNase
against aluminum binding. Aluminum did not bind to the incubated alkaline
RNase
-inhibitor complex, suggesting that aluminum might compete with RNase inhibitor for the binding site. However, the data from chemical modification and spectroscopic studies indicate that it is also highly possible that aluminum binding to the enzyme induces conformational changes at or near the inhibitor-binding site, which subsequently interrupt binding of RNase inhibitor to alkaline
RNase
. These results suggest that accumulation of aluminum in brain might affect the regulation of RNA metabolism.
...
PMID:Aluminum interrupts the formation of alkaline-ribonuclease-inhibitor complex from bovine brain. 193 68